A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients

Breast cancer is believed to result from the interplay of genetic and non-genetic risk factors, and individual genetic variation may influence the efficacy of chemotherapy. Here we conducted a genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with response t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lina, Yao, Lu, Zhang, Hong, Ouyang, Tao, Li, Jinfeng, Wang, Tianfeng, Fan, Zhaoqing, Fan, Tie, Lin, Benyao, Yin, C. Cameron, Xie, Yuntao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826264/
https://www.ncbi.nlm.nih.gov/pubmed/26573232
http://dx.doi.org/10.18632/oncotarget.5837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826264/
https://www.ncbi.nlm.nih.gov/pubmed/26573232
http://dx.doi.org/10.18632/oncotarget.5837

Ejemplares similares